Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 1,548 |
2 Jan 25 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
31 Dec 24 | RPRX Royalty Pharma | Class A Ordinary Shares | Grant | Acquire A | No | No | 24.9416 | 1,503 | 37.49 k | 61,299 |
17 Dec 24 | CDTX Cidara Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 22.81 | 16,000 | 364.96 k | 16,000 |
30 Sep 24 | RPRX Royalty Pharma | Class A Ordinary Shares | Grant | Acquire A | No | No | 27.9249 | 1,342 | 37.48 k | 59,796 |
15 Aug 24 | REGN Regeneron Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 1170 | 756 | 884.52 k | 1,382 |
15 Aug 24 | REGN Regeneron Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | Yes | 371.4 | 756 | 280.78 k | 2,138 |
15 Aug 24 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Option exercise | Dispose M | No | Yes | 371.4 | 756 | 280.78 k | 1,516 |